The Technical Analyst
Select Language :
Metacrine, Inc. [MTCR]

Exchange: NASDAQ Sector: Healthcare Industry: Biotechnology

Metacrine, Inc. Price, Forecast, Insider, Ratings, Fundamentals & Signals

Metacrine, Inc. is listed at the  Exchange

-1.29% $0.581

America/New_York / 20 jun 2023 @ 15:11


Metacrine, Inc.: Main Fundamentals PE comparison

FUNDAMENTALS
MarketCap: 25.48 mill
EPS: -1.030
P/E: -0.564
Earnings Date: Aug 08, 2023
SharesOutstanding: 43.83 mill
Avg Daily Volume: 0.0525 mill
RATING 2023-06-20
B-
Neutral
RATINGS
Rating CashFlow: Neutral
Return On Equity: Sell
Return On Asset: Sell
DE: Buy
P/E: Sell
Price To Book: Sell
QUARTER GROWTHS
2/213/214/211/222/223/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/an/a
Ebit
Asset
Debt
PE RATIO: COMPANY / SECTOR
0.00x
Company: PE -0.564 | sector: PE -3.05
PE RATIO: COMPANY / INDUSTRY
-0.10x
Company: PE -0.564 | industry: PE 5.88
DISCOUNTED CASH FLOW VALUE
N/A
N/A
Expected Trading Range (DAY)

$ 0.565 - 0.597

( +/- 2.75%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2023-03-23 Klassen Preston Sell 842 211 Common Stock
2023-03-23 Klassen Preston Sell 842 211 Stock Option (right to buy)
2023-01-26 York Michael Sell 107 054 Common Stock
2023-01-26 Klassen Preston Sell 380 605 Common Stock
2022-12-21 Leonard Braden Michael Buy 120 099 Common Stock
INSIDER POWER
-12.97
Last 97 transactions
Buy: 12 877 287 | Sell: 12 262 808

Forecast: 01:40 - $0.578

Live Trading Signals (every 1 min)

SCORE
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $0.581 (-1.29% )
Volume 0.0839 mill
Avg. Vol. 0.0525 mill
% of Avg. Vol 159.87 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Metacrine, Inc.

Last 12 Months

Last 12 months chart data with high, low, open and close for Metacrine, Inc.

RSI

Intraday RSI14 chart for Metacrine, Inc.

Last 10 Buy & Sell Signals For MTCR

0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%

Avg return buy: 0.00 % | Avg return sell: 0.00 %

$1 invested is now $1.00 or 0.00% since Coming Soon

Date Signal @ Closed %
Profile picture for
            Metacrine, Inc.

MTCR

Metacrine, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing therapies for patients with gastrointestinal diseases. It is developing MET642, which has completed Phase I clinical trial for the treatment of ulcerative colitis. Metacrine, Inc. was incorporated in 2014 and is headquartered in San Diego, California.

Last 10 Buy Signals

Date Signal @
ARBUSDMar 29 - 08:581.648
DASHUSDMar 29 - 08:57$39.61
NEXOUSDMar 29 - 08:531.331
BCHUSDMar 29 - 08:54$623.70
ROUTEUSDMar 29 - 08:504.37
OSMOUSDMar 29 - 08:451.380
BELUSDMar 29 - 08:440.982
DPIUSDMar 29 - 08:44$145.76
TIAUSDMar 29 - 08:3815.02
ETHUPUSDMar 29 - 08:3834.55

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.